Stan Lapidus is listed as a director on 4 SEC Form D filings by 2 issuers between May 2010 and Aug 2018: T2 Biosystems, Inc. (Lexington, MA — other health care — 2010–2013; $400M reported sold to 16 investors) and SunBird Bio, Inc. (Cambridge, MA — biotechnology — 2018; $46.7M reported sold to 19 investors).
What this means 2 separate companies raised money with this person listed as director, over about 8 years. Across those companies the filings report $446.7M sold in total.
Listed alongside Alan Crane (3 shared filings), John McDonough (3 shared filings), Michael Cima (3 shared filings), Michael Greeley (3 shared filings), Robert Langer (3 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stan. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Stan Lapidus and found 4 differences: Form D filed 17 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.